Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdds a recruitment status note indicating no further participant enrollment and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a version update (Revision: v3.6.0). Also includes a minor heading formatting adjustment for the Intervention/Treatment label.SummaryDifference0.4%

- Check20 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a minor site/template revision. No content related to the study details, criteria, or results appears to be affected.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page displays Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a new build version of the site.SummaryDifference0.0%

- Check63 days agoChange DetectedThis update reflects a change to the ClinicalTrials.gov page/version revision label (from v3.5.0 to v3.5.3), indicating a site release rather than a change to the study record itself.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated the terminology to 'Alpha-1-antitrypsin deficiency' to ensure consistent hyphenation with 'Alpha-1' across the page.SummaryDifference0.0%

- Check99 days agoChange DetectedSite revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.